Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.
Point-of-care MRI is a worthwhile diagnostic option for emergency departments and ICUs concerned about wait or transport times to access fixed MRI for patients with neuroimaging needs.
GE Healthcare introduced a new fixed radiography system Aug. 2, positioning it at the high end of the category and spotlighting its capabilities as the most advanced in its family.
Surveying the landscape of well-paying jobs in reach of individuals with two-year degrees, a popular technology-business news outlet has found three of the top 10 exist within the radiological sphere.
Data scientists and software engineers at the University of Arkansas have been awarded more than $140,000 by the NIH to educate biomedical researchers on the growing role of AI in big-data analytics.
A state attorney general has indicted the physician owner of an imaging center for bribing colleagues to order unnecessary exams before performing the exams—including some with IV contrast—and submitting false claims to CMS.
In an initial comparison study involving 10 patients with high-risk prostate cancer, ultrasound tomography (UT) soundly beat 7-Tesla multiparametric MRI on detection sensitivity, 85.7% to 65.3%.